Ftse Mib
34.513,04
-0,42%
DAX
18.607,36
-0,41%
S&P 500
5.306,04
0,02%
NASDAQ
17.019,88
0,59%
Bitcoin
67.824,27
-0,68%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ocular Therapeutix Inc (OCUL) Ocular Therapeutix Inc (OCUL) Notizie

Ocular Therapeutix Inc

OCUL
5,93
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:05:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/5/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:18EDGAR2Form 144 - Report of proposed sale of securities
23/5/202422:16EDGAR2Form 144 - Report of proposed sale of securities
07/5/202422:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/5/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:05GLOBEOcular Therapeutix™ Reports First Quarter 2024 Results
07/5/202422:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/5/202402:16GLOBEOcular Therapeutix Reports Inducement Grants Under Nasdaq..
06/5/202413:30GLOBEOcular Therapeutix™ to Present at Two Upcoming Investor..
03/5/202413:30GLOBEOcular Therapeutix™ To Present at Two Ophthalmology..
01/5/202413:30GLOBEOcular Therapeutix™ to Host Investor Day in New York City on..
11/3/202421:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/3/202421:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202421:10EDGAR2Form 8-K - Current report
11/3/202411:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
27/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202402:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/2/202402:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/2/202414:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202413:34EDGAR2Form 8-K - Current report
19/2/202415:00PRNUSAffaMed Therapeutics Announces New Drug Application..
15/2/202414:00GLOBEOcular Therapeutix™ Appoints Steve Meyers to Chief..
15/2/202401:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202413:37GLOBEOcular Therapeutix™ Announces First Subjects Screened in..
07/2/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202422:41EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:39EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:36EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:33EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:30EDGAR2Form 144 - Report of proposed sale of securities
03/2/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:41EDGAR2Form 144 - Report of proposed sale of securities
31/1/202423:39EDGAR2Form 144 - Report of proposed sale of securities
31/1/202423:36EDGAR2Form 144 - Report of proposed sale of securities
31/1/202423:34EDGAR2Form 144 - Report of proposed sale of securities
31/1/202423:31EDGAR2Form 144 - Report of proposed sale of securities
25/1/202414:04EDGAR2Form 8-K - Current report
28/12/202322:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22/12/202322:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
Apertura: Min: Max:
Chiusura: 5,93

La tua Cronologia

NASDAQ
OCUL
Ocular Therapeutix
BIT
P1SQ28
BNP Paribas Issuance
TSX
EAGR
East Side Games
LBNK
AIDOGEUSDT
AIDOGE
COIN
LTHGBP
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network